Editorial Expression of Concern: Implantation of a Novel Allogeneic Mesenchymal Precursor Cell Type in Patients with Ischemic Cardiomyopathy Undergoing Coronary Artery Bypass Grafting: an Open Label Phase IIa Trial
J Cardiovasc Transl Res
.
2021 Jun;14(3):587-588.
doi: 10.1007/s12265-020-10076-7.
Authors
Kyriakos Anastasiadis
1
,
Polychronis Antonitsis
2
,
Stephen Westaby
3
,
Ajan Reginald
4
,
Sabena Sultan
4
,
Argirios Doumas
5
,
George Efthimiadis
6
,
Martin John Evans
4
Affiliations
1
Cardiothoracic Department, AHEPA University Hospital, S. Kyriakidi 1, 546 36, Thessaloniki, Greece.
2
Cardiothoracic Department, AHEPA University Hospital, S. Kyriakidi 1, 546 36, Thessaloniki, Greece. antonits@auth.gr.
3
The John Radcliffe Hospital, Oxford University Hospitals, Headington, Oxford, UK.
4
Cell Therapy Ltd., Celixir House, Innovation Way, Stratford upon Avon, UK.
5
Department of Nuclear Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
6
First Cardiology Department, AHEPA University Hospital, Thessaloniki, Greece.
PMID:
33078376
DOI:
10.1007/s12265-020-10076-7
No abstract available
Publication types
Published Erratum
Expression of Concern